These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 9406146)

  • 1. An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development.
    Buttar HS
    Mol Cell Biochem; 1997 Nov; 176(1-2):61-71. PubMed ID: 9406146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of inhibition of the maternal renin-angiotensin system on maternal and fetal responses to drainage of fetal fluids.
    Lumbers ER; Bernasconi C; Burrell JH
    Can J Physiol Pharmacol; 1996 Aug; 74(8):973-82. PubMed ID: 8960388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of angiotensin II type 1 receptor blockade and angiotensin-converting enzyme inhibition in pregnant sheep during late gestation.
    Forhead AJ; Whybrew K; Hughes P; Broughton Pipkin F; Sutherland M; Fowden AL
    Br J Pharmacol; 1996 Sep; 119(2):393-401. PubMed ID: 8886426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the maternal and fetal renin-angiotensin systems in response to angiotensin II type 1 receptor blockade and angiotensin-converting enzyme inhibition in pregnant sheep during late gestation.
    Forhead AJ; Broughton Pipkin F; Sutherland MF; Fowden AL
    Exp Physiol; 1997 Jul; 82(4):761-76. PubMed ID: 9257117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks of angiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use.
    Shotan A; Widerhorn J; Hurst A; Elkayam U
    Am J Med; 1994 May; 96(5):451-6. PubMed ID: 8192177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of a converting enzyme inhibitor (captopril) and angiotensin II on fetal renal function.
    Lumbers ER; Burrell JH; Menzies RI; Stevens AD
    Br J Pharmacol; 1993 Oct; 110(2):821-7. PubMed ID: 8242257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
    Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Captopril use in pregnancy and its effects on the fetus and the newborn: case report].
    Sadeck LS; Fernandes M; Silva SM; Trindade AA; Chia CY; Ramos JL; Leone CR
    Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(6):328-32. PubMed ID: 9629744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetotoxic risk of AT1 blockers exceeds that of angiotensin-converting enzyme inhibitors: an observational study.
    Weber-Schoendorfer C; Kayser A; Tissen-Diabaté T; Winterfeld U; Eleftheriou G; Te Winkel B; Diav-Citrin O; Greenall A; Hoeltzenbein M; Schaefer C
    J Hypertens; 2020 Jan; 38(1):133-141. PubMed ID: 31568057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of fetal and neonatal renal impairment by pharmacologic inhibition of angiotensin.
    Chevalier RL
    Curr Med Chem; 2012; 19(27):4572-80. PubMed ID: 22876894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibition with quinapril (CI-906) and captopril in spontaneously hypertensive rats with suppressed renin-angiotensin system.
    Säynävälammi P; Pörsti I
    Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):325-31. PubMed ID: 3309510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term suppression of the renin-angiotensin system in mice associated with hypertension during pregnancy.
    Ishimaru T; Ishida J; Nakamura S; Hashimoto M; Matsukura T; Nakamura A; Kunita S; Sugiyama F; Yagami K; Fukamizu A
    Mol Med Rep; 2012 Jul; 6(1):28-32. PubMed ID: 22552605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal effects of maternally administered clonidine and angiotensin-converting enzyme inhibitors.
    Boutroy MJ
    Dev Pharmacol Ther; 1989; 13(2-4):199-204. PubMed ID: 2693003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
    Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
    Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review.
    Bullo M; Tschumi S; Bucher BS; Bianchetti MG; Simonetti GD
    Hypertension; 2012 Aug; 60(2):444-50. PubMed ID: 22753220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists.
    Quan A
    Early Hum Dev; 2006 Jan; 82(1):23-8. PubMed ID: 16427219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.